Trans-Atlantic RetroPeritoneal Sarcoma Working Group

A collaborative group for Surgical Oncologists and Sarcoma Professionals

RESAR Study

REtroperitoneal SArcoma Registry (RESAR): prospective collection of primary retroperitoneal sarcoma patient’s data, radiological and pathological material for the TransAtlantic Retroperitoneal Sarcoma Working Group.

Activation track of the study (updated September 30th 2018)

Documents for activation of RESAR at new centers are available here.

City Institution State Activation Status
Amsterdam Netherlands Cancer Institute The Netherlands Submitted to IRB, pending for decision
Atlanta Winship Cancer Institute, Emory University Georgia, USA Recruiting
Baton Rouge Mary Bird Perkins Cancer Center Louisiana, USA Submitted to IRB, pending for decision
Birmingham Queen Elizabeth Hospital Birmingham UK Recruiting
Bordeaux Institut Bergonié France Planning to submit to IRB
Boston Brigham and Women’s Hospital/Dana-Farber Cancer Institute Massachusetts, USA Recruiting
Boston Massachusetts General Hospital Massachusetts, USA Planning to submit to IRB
Buffalo Roswell Park Comprehensive Cancer Center New York, USA Recruiting
Candiolo Candiolo Cancer Institute Italy Planning to submit to IRB
Columbus The Ohio State University Ohio, USA Recruiting
Hong Kong The Chinese University of Hong Kong / Prince of Wales Hospital Hong Kong Planning to submit to IRB
Jacksonville Mayo Clinic Florida, USA Recruiting
Leiden Leiden University Medical Center The Netherlands Submitted to IRB, pending for decision
Ljubljana Institute of Oncology Ljubljana Slovenia Recruiting
London Royal Marsden Hospital UK Recruiting
Los Angeles University of Southern California (USC) California, USA Recruiting
Mannheim University Medical Center and Medical Faculty Mannheim, University of Heidelberg Germany Approved, ready to recruit
Melbourne Peter MacCallum Cancer Center Victoria, Australia Recruiting
Milano Fondazione IRCCS Istituto Nazionale dei Tumori Italy Recruiting
Milano European Institute of Oncology Italy Planning to submit to IRB
Montreal Maisonneuve-Rosemont Hospital / University of Montreal Quebec, Canada Approved, ready to recruit
Munich Ludwig Maximilian University Germany Recruiting
Murcia Hospital Clinico Universitario “Virgen de la Arrixaca” Spain Recruiting
Ottawa The Ottawa Hospital Ontario, Canada Recruiting
Padova Veneto Institute of Oncology Italy Recruiting
Paris Institut Curie France Recruiting
Philadelphia Fox Chase Cancer Center Mariland, USA Planning to submit to IRB
Roma Campus Biomedico Italy Recruiting
Sacramento UC Davis California, USA Planning to submit to IRB
Seattle University of Washington Washington, USA Planning to submit to IRB
Seoul Samsung Medical Center South Corea Recruiting
Tampa Moffitt Cancer Center Florida, USA Recruiting
Tokyo National Cancer Center Hospital Japan Planning to submit to IRB
Toronto Mount Sinai / Princess Margaret Canada Recruiting
Turin Città della Salute e della Scienza Italy Submitted to IRB, pending for decision
Vellore Christian Medical College India Planning to submit to IRB
Verona Ospedale Borgo Roma Italy Recruiting
Warsaw  Maria Sklodowska-Curie Memorial Cancer Center and Institute ofOncology, Warsaw, Poland Recruiting
%d bloggers like this: